These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38447414)

  • 21. Scrutinizing the Expression and Blockade of Inhibitory Molecules Expressed on T Cells from Acute Myeloid Leukemia Patients.
    Abdolmaleki M; Mojtabavi N; Zavvar M; Vaezi M; Noorbakhsh F; Nicknam MH
    Iran J Allergy Asthma Immunol; 2018 Jun; 17(3):265-273. PubMed ID: 29908544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute Myeloid Leukemia Cells Express ICOS Ligand to Promote the Expansion of Regulatory T Cells.
    Han Y; Dong Y; Yang Q; Xu W; Jiang S; Yu Z; Yu K; Zhang S
    Front Immunol; 2018; 9():2227. PubMed ID: 30319662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Higher PD-1/Tim-3 expression on IFN-γ+ T cells is associated with poor prognosis in patients with acute myeloid leukemia.
    Huang S; Zhao Y; Lai W; Tan J; Zheng X; Zha X; Li Y; Chen S
    Cancer Biol Ther; 2023 Dec; 24(1):2278229. PubMed ID: 37962843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T-Cell Immunoglobulin and ITIM Domain (TIGIT) Associates with CD8+ T-Cell Exhaustion and Poor Clinical Outcome in AML Patients.
    Kong Y; Zhu L; Schell TD; Zhang J; Claxton DF; Ehmann WC; Rybka WB; George MR; Zeng H; Zheng H
    Clin Cancer Res; 2016 Jun; 22(12):3057-66. PubMed ID: 26763253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Signatures of CD8+ T cell dysfunction in AML patients and their reversibility with response to chemotherapy.
    Knaus HA; Berglund S; Hackl H; Blackford AL; Zeidner JF; Montiel-Esparza R; Mukhopadhyay R; Vanura K; Blazar BR; Karp JE; Luznik L; Gojo I
    JCI Insight; 2018 Nov; 3(21):. PubMed ID: 30385732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Higher TIGIT
    Jin Z; Lan T; Zhao Y; Du J; Chen J; Lai J; Xu L; Chen S; Zhong X; Wu X; Li Y
    Immunol Invest; 2022 Jan; 51(1):40-50. PubMed ID: 32819181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TIGIT blockade repolarizes AML-associated TIGIT
    Brauneck F; Fischer B; Witt M; Muschhammer J; Oelrich J; da Costa Avelar PH; Tsoka S; Bullinger L; Seubert E; Smit DJ; Bokemeyer C; Ackermann C; Wellbrock J; Haag F; Fiedler W
    J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36549780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. After Treatment Decrease of Bone Marrow Tregs and Outcome in Younger Patients with Newly Diagnosed Acute Myeloid Leukemia.
    Delia M; Carluccio P; Mestice A; Frappampina R; Albano F; Specchia G; Musto P
    J Immunol Res; 2020; 2020():2134647. PubMed ID: 33204734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A skewed distribution and increased PD-1+Vβ+CD4+/CD8+ T cells in patients with acute myeloid leukemia.
    Huang J; Tan J; Chen Y; Huang S; Xu L; Zhang Y; Lu Y; Yu Z; Chen S; Li Y
    J Leukoc Biol; 2019 Sep; 106(3):725-732. PubMed ID: 31136687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blocking migration of regulatory T cells to leukemic hematopoietic microenvironment delays disease progression in mouse leukemia model.
    Wang R; Feng W; Wang H; Wang L; Yang X; Yang F; Zhang Y; Liu X; Zhang D; Ren Q; Feng X; Zheng G
    Cancer Lett; 2020 Jan; 469():151-161. PubMed ID: 31669202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcriptional profiling demonstrates altered characteristics of CD8
    Abolhalaj M; Sincic V; Lilljebjörn H; Sandén C; Aab A; Hägerbrand K; Ellmark P; Borrebaeck CAK; Fioretos T; Lundberg K
    Cancer Med; 2022 Aug; 11(15):3023-3032. PubMed ID: 35297213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increasing Tim-3+CD244+, Tim-3+CD57+, and Tim-3+PD-1+ T cells in patients with acute myeloid leukemia.
    Tan J; Huang S; Huang J; Yu Z; Chen Y; Lu Y; Li Y; Chen S
    Asia Pac J Clin Oncol; 2020 Jun; 16(3):137-141. PubMed ID: 32030888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. STAT5 promotes PD-L1 expression by facilitating histone lactylation to drive immunosuppression in acute myeloid leukemia.
    Huang ZW; Zhang XN; Zhang L; Liu LL; Zhang JW; Sun YX; Xu JQ; Liu Q; Long ZJ
    Signal Transduct Target Ther; 2023 Sep; 8(1):391. PubMed ID: 37777506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD8 + T cell-based molecular subtypes with heterogeneous immune landscapes and clinical significance in acute myeloid leukemia.
    Zhong F; Yao F; Jiang J; Yu X; Liu J; Huang B; Wang X
    Inflamm Res; 2024 Mar; 73(3):329-344. PubMed ID: 38195768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemia.
    Lamble AJ; Kosaka Y; Laderas T; Maffit A; Kaempf A; Brady LK; Wang W; Long N; Saultz JN; Mori M; Soong D; LeFave CV; Huang F; Adams H; Loriaux MM; Tognon CE; Lo P; Tyner JW; Fan G; McWeeney SK; Druker BJ; Lind EF
    Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14331-14341. PubMed ID: 32513686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartment.
    Schnorfeil FM; Lichtenegger FS; Emmerig K; Schlueter M; Neitz JS; Draenert R; Hiddemann W; Subklewe M
    J Hematol Oncol; 2015 Jul; 8():93. PubMed ID: 26219463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer immunotherapy with PI3K and PD-1 dual-blockade via optimal modulation of T cell activation signal.
    Isoyama S; Mori S; Sugiyama D; Kojima Y; Tada Y; Shitara K; Hinohara K; Dan S; Nishikawa H
    J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34446575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors.
    Duraiswamy J; Kaluza KM; Freeman GJ; Coukos G
    Cancer Res; 2013 Jun; 73(12):3591-603. PubMed ID: 23633484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased lactate in AML blasts upregulates TOX expression, leading to exhaustion of CD8
    Chen Y; Feng Z; Kuang X; Zhao P; Chen B; Fang Q; Cheng W; Wang J
    Am J Cancer Res; 2021; 11(11):5726-5742. PubMed ID: 34873490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulatory T cells-derived IL-35 promotes the growth of adult acute myeloid leukemia blasts.
    Tao Q; Pan Y; Wang Y; Wang H; Xiong S; Li Q; Wang J; Tao L; Wang Z; Wu F; Zhang R; Zhai Z
    Int J Cancer; 2015 Nov; 137(10):2384-93. PubMed ID: 25866142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.